TABLE 3.

Characteristics of and outcomes for 19 patients with staphylococcal infections of their osteosynthetic devices^a

Patient no.	Sex	Age (yr)	Time delay to infection (mo)	Clinical presentation	Localization	Type of device	Microorganism	Diagnostic procedure	Previous treatment	Device removal	Outcome	Duration of follow-up (mo)
21	F	22	9	P, Fi, I	Ankle	Pl	CoNS	Fistula		No	Intolerance
22	M	32	6	Fi, I	Knee	Pl	SA	Fistula		No	Intolerance
23	F	26	3	P, Fi	Tibia	Pl	SA	Fistula		Yes	Cure	49
24	M	41	7	P, Fe	Tibia	Pl	CoNS	Biopsy		Yes	Cure	39
25	M	23	2	P, Fe, I	Femur	Pl	SA	Biopsy		Yes	Cure	37
26	M	44	10	P, Fi, I	Tibia	IMN	CoNS	Fistula	O/R	No	Cure	45
27	M	47	1	P, Fi	Tibia	Pl	CoNS	Fistula		No	Cure	54
28	F	22	9	P, Fi	Ankle	Pl	SA	Fistula		No	Cure	57
29	M	53	1	Fi	Ankle	Pl	SA	Fistula		No	Cure	75
30	F	58	6	P, Fi, I	Tibia	IMN	CoNS	Fistula	O/R	No	Cure	65
31	M	28	2	P, Fe, I	Tibia	Pl	SA	Biopsy		Yes	Cure	48
32	F	36	4	P, Fi	Ankle	Pl	CoNS	Fistula		No	Cure	52
33	M	35	20	Fi	Tibia	Pl	SA	Fistula	F/R	Yes	Cure	45
34	M	16	7	P, I	Tibia	Pl	SA	Puncture		No	Intolerance
35	M	50	2	P, Fi, I	Tibia	Pl	SA	Fistula		Yes	Cure	73
36	M	22	1	P, Fe, Fi	Tibia	IMN	SA	Fistula		No	Cure	24
37	F	37	11	Fi	Ankle	Pl	SA	Fistula		No	Cure	49
38	M	43	4	P, Fi	Tibia	Pl	SA	Fistula		No	Cure	25
39	M	29	5	P, Fi, I	Tibia	Pl	SA	Fistula		No	Intolerance

^aAbbreviations: SA, S. aureus; CoNS, coagulase-negative Staphylococcus; M, male; F, female; P, pain; Fe, fever; Fi, fistula; I, inflammatory syndrome; Pl, plate; IMN, intramedullary nail; O/R, ofloxacin plus rifampin; F/R, fusidic acid plus rifampin.